Open Access

Therapeutic effects of paeonol on non‑small cell lung cancer cells via regulation of the MAPK pathway

  • Authors:
    • Wen Gan
    • Chong Chen
    • Miaolong Huang
    • Youtao Li
  • View Affiliations

  • Published online on: September 24, 2024     https://doi.org/10.3892/ol.2024.14693
  • Article Number: 560
  • Copyright: © Gan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to investigate the molecular mechanisms by which paeonol impedes DNA damage repair, induces apoptosis and inhibits cell viability via the mitogen‑activated protein kinase (MAPK) pathway. Firstly, normal human bronchial epithelial cells (BEAS‑2B) and non‑small cell lung cancer cells (H1299) were employed in the study as cellular models. Following cultivation, the cells were divided into experimental and control groups, and were treated with different concentrations of paeonol. Subsequently, various techniques, including western blotting, Cell Counting Kit‑8, colony formation, TUNEL and comet assays were conducted to evaluate the effects of paeonol on cell viability, colony‑forming ability, apoptosis levels and DNA damage in H1299 cells. According to the experimental results, paeonol significantly reduced the viability and colony formation ability of H1299 cells, but substantially increased apoptosis and DNA damage. These effects were enhanced in response to higher concentrations of paeonol. Furthermore, western blot analysis revealed that paeonol treatment decreased the protein levels of B‑cell lymphoma 2 and breast cancer susceptibility gene 1, while it increased the expression levels of cleaved‑PARP, cleaved‑caspase 3, γH2AX and P21. Additionally, the phosphorylated levels of extracellular signal‑regulated kinase 1, c‑Jun N‑terminal kinase and P38 within the MAPK signaling pathway were diminished. Collectively, the present study demonstrated that paeonol may inhibit the metabolic activity and proliferative capability of H1299 cells, and that it could promote apoptosis and obstruct DNA damage repair by modulating the MAPK signaling pathway.
View Figures
View References

Related Articles

Journal Cover

December-2024
Volume 28 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gan W, Chen C, Huang M and Li Y: Therapeutic effects of paeonol on non‑small cell lung cancer cells via regulation of the MAPK pathway. Oncol Lett 28: 560, 2024.
APA
Gan, W., Chen, C., Huang, M., & Li, Y. (2024). Therapeutic effects of paeonol on non‑small cell lung cancer cells via regulation of the MAPK pathway. Oncology Letters, 28, 560. https://doi.org/10.3892/ol.2024.14693
MLA
Gan, W., Chen, C., Huang, M., Li, Y."Therapeutic effects of paeonol on non‑small cell lung cancer cells via regulation of the MAPK pathway". Oncology Letters 28.6 (2024): 560.
Chicago
Gan, W., Chen, C., Huang, M., Li, Y."Therapeutic effects of paeonol on non‑small cell lung cancer cells via regulation of the MAPK pathway". Oncology Letters 28, no. 6 (2024): 560. https://doi.org/10.3892/ol.2024.14693